Exited position

Warren Buffett’s UnitedHealth Group (UNH) position

Reported position history, portfolio importance and verified filing changes from public SEC disclosures.

Berkshire HathawayVerified through Q2 2026
Relationship snapshot

At a glance

The full verified relationship, including prior ownership episodes and exits where supported.

First reportedQ1 2007Earliest verified positive filing snapshot
Latest statusExited positionBased on the latest supported relationship state
Peak shares6.40MHighest verified quarter-end share count
Quarters reported15Verified quarters with shares above zero
What happened?

Berkshire Hathaway first reported UnitedHealth Group in Q1 2007. The reported position was increased and reduced across later filings. The latest verified relationship event shows that Berkshire Hathaway sold the entire position in Q1 2026, and the stock is no longer reported in the latest verified portfolio.

Verified SEC history

Position over time

See the same verified relationship through reported shares, portfolio weight or reported value.

Metric

Gaps indicate periods that cannot be safely connected or where a verified corporate action changes the raw share scale. Stock price, when available, is market context and not a transaction price.

Key filing events

What changed

Latest filing plus the most meaningful reported changes. Unchanged quarters are collapsed by default.

Q1 2026
Sold the entire position−5.04M shares · No shares reported at quarter-end
Q2 2025
New position+5.04M shares · 5.04M shares reported
Filing context

Quarter-end price $311.97 · Estimated holding basis $311.97

Q1 2010
Sold the entire position−1.18M shares · No shares reported at quarter-end
Q4 2009
Sold 65.4% of the position−2.23M shares · 1.18M shares remained
Filing context

Quarter-end price $30.48 · Estimated holding basis $49.88

Q2 2009
Sold 24.4% of the position−1.10M shares · 3.40M shares remained
Filing context

Quarter-end price $24.98 · Estimated holding basis $49.88

Q1 2009
Sold 28.6% of the position−1.80M shares · 4.50M shares remained
Filing context

Quarter-end price $20.93 · Estimated holding basis $49.88

5 unchanged quarters are collapsed by default.

Portfolio importance

How important was UnitedHealth Group in Berkshire Hathaway’s reported portfolio?

Relative importance is measured only within the verified primary non-option reported portfolio for each quarter.

Last reported portfolio weight0.6%Q4 2025
Last reported rank#19of 42 reported positions
Peak portfolio weight0.7%Q3 2025
Best historical rank#18Q2 2025
At peak importanceQ3 2025
UNH
0.7%
Largest holding
22.7%
Cross-investor discovery

Who else owns UnitedHealth Group?

Also reported by 4 other tracked investors in their latest verified filings.

Chase ColemanTiger Global Management LLC
UNH0.5% of reported portfolio
Joel GreenblattGotham Asset Management
UNH0.1% of reported portfolio
George SorosSoros Fund Management
UNH0.0% of reported portfolio
Explore UnitedHealth Group across all tracked investors →
SEC evidence & methodology

SEC filing evidence

Market context and filing-derived values are kept separate from actual transaction prices, which 13F filings do not disclose.

Latest verified stock price$379.092026-09-11

Market context only; not an investor transaction price.

Latest verified investor filingQ2 2026 · filed 2026-08-14
Open SEC filing ↗

View UnitedHealth Group stock page →

This tracker follows Berkshire Hathaway’s Form 13F disclosures. It is not Warren Buffett’s personal brokerage account, and 13F filings do not reveal exact trade dates or execution prices.